Benzodiazepines and Opioid Use May Result in Respiratory Compromise and Death

Position statement on benzodiazepines and opioids by the Physician-Patient Alliance for Health & Safety
 
"Reducing Adverse Drug Events Related to Opioids"
"Reducing Adverse Drug Events Related to Opioids"
CHICAGO - May 31, 2018 - PRLog -- Using benzodiazepines and opioids may be a deadly combination. According to the National Institute on Drug Abuse, more than 30% of opioid overdoses involve the use of benzodiazepines.

One of the commonly overlooked complications to safe opioid administration is failing to account for the additive sedation effects of non-opioid medication. In recognition of these dangers, in August 2016, the FDA issued its strongest warning about combined use of opioids and benzodiazepines and issued another caution more recently on September 20, 2017.

To further emphasize that the concomitant use of benzodiazepines and opioids may be a deadly combination, the Physician-Patient Alliance for Health & Safety released a position statement, "Patients Receiving Benzodiazepines, in Combination with Opioid Analgesics, May Suffer from Respiratory Compromise and Death."

"In order to avoid respiratory compromise and death, there must be significant caution and monitoring of patients receiving benzodiazepines and other sedatives," said Michael Wong (Founder and Executive Director,  particularly when received in combination with opioids. Physician-Patient Alliance for Health & Safety, "particularly when received in combination with opioids."

To help prevent respiratory compromise and death in patients receiving an opioid analgesic and a benzodiazepine or other sedative, the Physician-Patient Alliance for Health & Safety recommends:
  • When a patient is admitted to hospital, it is essential for clinicians to recognize and understand the syndromes of respiratory compromise.
  • During hospitalization, patients, who receive an opioid analgesic and a benzodiazepine or other sedative, be placed on a more aggressive monitoring plan, preferably with continuous electronic monitoring by pulse oximetry to measure oxygenation and capnography to measure the adequacy of ventilation.
For more on benzodiazepines and opioids, and opioid-related adverse events, please listen to this clinical education podcast with Thomas W. Frederickson MD, FACP, SFHM, MBA, lead author of the Society of Hospital Medicine's Reducing Adverse Drug Events related to Opioids Guide - https://youtu.be/cAEhjSkPkKM



To read a pdf of the PPAHS position statement on benzodiazepines, please click here.

About Physician-Patient Alliance for Health & Safety

Physician-Patient Alliance for Health & Safety is a non-profit 501(c)(3) whose mission is to promote safer clinical practices and standards for patients through collaboration among healthcare experts, professionals, scientific researchers, and others, to improve healthcare delivery. For more information, please go to www.ppahs.org.

Contact
Michael Wong, JD (Executive Director)
***@ppahs.org

Photo:
https://www.prlog.org/12711087/1
End
Email:***@ppahs.org Email Verified
Tags:Benzodiazepines, Opioids, Opioid Overdose, Opioid Epidemic
Industry:Health, Medical, Non-profit
Location:Chicago - Illinois - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share